Servier’s Post

View organization page for Servier, graphic

451,298 followers

🎉 Congratulations to kyron.bio, winner of our Golden Ticket to Spartners by Servier & BioLabs France! kyron.bio is at the forefront of synthetic biology, developing advanced biomanufacturing processes for sustainable production. Their expertise lies in engineering microorganisms to produce high-value compounds, addressing global challenges in health, agriculture, and the environment with eco-friendly and cost-effective solutions. As a part of this year’s contest, kyron.bio will benefit from the latest research equipment, shared infrastructure, and numerous programs and services offered in Spartners by Servier & BioLabs. Learn more about Spartners by Servier & BioLabs France 👉 https://lnkd.in/eBa9FKzG #innovation #startup #biotech

Pat PH

Consultant senior dans les domaines de la Santé et en particulier l'industrie pharmaceutique au niveau mondial.

2w

It's a good job. After for drugs you need clinical trials that could take 10 years and finance. All the big pharmas do it in Boston. USA gets free price for new drugs and become a reference for Europe for EMA and price. Servier decided to get rid off Biogaran. Is it to try to come back to the circle of big pharmas ? The advantage of blockbusters is a high margin and a few people. It's not the case of metoo drugs even if Biogaran is positive but less margin and sale. Like Sanofi you believe to science miracle ? For that you have to believe in god. Anyway if Indians will buy Biogaran they will have the raw materials. So they will have a better margin.

Like
Reply

To view or add a comment, sign in

Explore topics